Obinutuzumab is a potent anti-B cell drug already approved to treat lupus nephritis, chronic lymphocytic leukemia, and follicular lymphoma. Therapies targeting B cells are perhaps the most effective ...
A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.
Players don't receive a lifetime ban until a third PED violation. Perhaps it's time to reconsider the current penalties for ...
Almost 90% of illegal steroids contain unexpected, incorrect or dangerous substances, a Queensland drug testing study has ...
Drugs tests on rugby players in South Africa have plunged more than sixfold in the last decade, Telegraph Sport can reveal.
The FDA expanded the indication of the long-acting growth hormone somapacitan (Sogroya) to include very young children with idiopathic short stature, short stature born small for gestational age, or ...
Pitha and colleagues observed a general correlation between patterns of ophthalmic medication and total drug shortage reports in the US. Though ophthalmic drug shortages accounted for 15% of all ...
A new Ohio University study offers a glimmer of hope in the fight against lung cancer. Monica Robins has that story and more ...
Well, good morning, everybody, and thank you once again for joining us for the 46th Annual TD Cowen Healthcare Conference. I'm Yaron Werber from the biotech team, and it's a great pleasure to moderate ...
Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...
FDA assigns PDUFA target action date in the third quarter of calendar year 2026 with launch expected at the end of September 2026Priority Review ...
The research shows that these muscle-building drugs may raise the risk of a dangerous heart rhythm problem called atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results